STOCK TITAN

[144] Lantheus Holdings, Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filed for Lantheus Holdings, Inc (LNTH) discloses an intended sale of 3,060 common shares through Fidelity Brokerage with an aggregate market value of $163,924.20. The filing lists the approximate sale date as 08/13/2025 and identifies the securities exchange as NASDAQ. The shares to be sold were acquired through company programs: 221 shares via an ESPP purchase on 03/13/2023 (paid in cash) and 2,839 shares from restricted stock vesting on 03/02/2024, 03/03/2024, and 04/17/2024 as compensation.

The filing also reports a prior sale by Paul Blanchfield of 6,599 common shares on 06/05/2025 for gross proceeds of $525,610.35. Certain filer identification fields appear blank in the provided content. The document includes the standard seller representation that they have no undisclosed material adverse information.

Form 144 presentato per Lantheus Holdings, Inc (LNTH) segnala l'intenzione di vendere 3,060 azioni ordinarie tramite Fidelity Brokerage per un valore di mercato complessivo di $163,924.20. Il modulo indica la data approssimativa di vendita come 08/13/2025 e identifica il mercato come NASDAQ. Le azioni da vendere sono state acquisite tramite programmi aziendali: 221 azioni tramite un acquisto ESPP il 03/13/2023 (pagate in contanti) e 2,839 azioni risultanti dal vesting di restricted stock in data 03/02/2024, 03/03/2024 e 04/17/2024 come compenso.

La segnalazione riporta inoltre una vendita precedente di Paul Blanchfield di 6,599 azioni ordinarie il 06/05/2025 per proventi lordi di $525,610.35. Alcuni campi identificativi del dichiarante appaiono vuoti nel contenuto fornito. Il documento include la consueta dichiarazione del venditore secondo cui non esistono informazioni negative materiali non divulgate.

El Formulario 144 presentado para Lantheus Holdings, Inc (LNTH) revela la intención de vender 3,060 acciones ordinarias a través de Fidelity Brokerage por un valor de mercado agregado de $163,924.20. La presentación indica la fecha aproximada de venta como 08/13/2025 y identifica la bolsa como NASDAQ. Las acciones a vender se adquirieron mediante programas de la compañía: 221 acciones por una compra del ESPP el 03/13/2023 (pagadas en efectivo) y 2,839 acciones procedentes del vesting de restricted stock el 03/02/2024, 03/03/2024 y 04/17/2024 como compensación.

La presentación también informa de una venta anterior por parte de Paul Blanchfield de 6,599 acciones ordinarias el 06/05/2025 por unos ingresos brutos de $525,610.35. Algunos campos de identificación del declarante aparecen en blanco en el contenido proporcionado. El documento incluye la declaración estándar del vendedor de que no dispone de información material adversa no divulgada.

Form 144 제출서 — Lantheus Holdings, Inc (LNTH)에 따르면 Fidelity Brokerage를 통해 보통주 3,060주를 매도할 예정이며 총 시가총액은 $163,924.20입니다. 신고서에는 예정 매도일을 08/13/2025로 기재하고 있으며 거래소는 NASDAQ으로 명시되어 있습니다. 매도 예정 주식은 회사 프로그램을 통해 취득한 것으로, 221주는 ESPP 매수(일자: 03/13/2023, 현금 결제)를 통해 취득했고, 2,839주는 보상으로서 제한주(Restricted Stock)의 베스팅으로 03/02/2024, 03/03/2024, 04/17/2024에 취득했습니다.

신고서에는 또한 Paul Blanchfield06/05/2025에 보통주 6,599주를 매도해 총 $525,610.35의 총수익을 올렸다고 보고되어 있습니다. 제공된 내용에서는 일부 제출자 식별 필드가 비어 있는 것으로 보입니다. 문서에는 공개되지 않은 중대한 불리한 정보가 없다는 판매자 표준 진술이 포함되어 있습니다.

Le formulaire 144 déposé pour Lantheus Holdings, Inc (LNTH) indique l'intention de vendre 3,060 actions ordinaires via Fidelity Brokerage pour une valeur de marché totale de $163,924.20. Le dépôt mentionne la date approximative de vente comme 08/13/2025 et identifie la bourse comme NASDAQ. Les actions à vendre ont été acquises par le biais de programmes de l'entreprise : 221 actions via un achat ESPP le 03/13/2023 (payées en espèces) et 2,839 actions résultant du vesting de restricted stock le 03/02/2024, 03/03/2024 et 04/17/2024 en tant que rémunération.

Le dépôt signale aussi une vente antérieure par Paul Blanchfield de 6,599 actions ordinaires le 06/05/2025 pour un produit brut de $525,610.35. Certains champs d'identification du déclarant semblent vides dans le contenu fourni. Le document inclut la déclaration standard du vendeur selon laquelle il n'existe pas d'informations défavorables importantes non divulguées.

Form 144 eingereicht für Lantheus Holdings, Inc (LNTH) offenbart die beabsichtigte Veräußerung von 3,060 Stammaktien über Fidelity Brokerage mit einem aggregierten Marktwert von $163,924.20. Die Einreichung nennt das ungefähre Verkaufsdatum als 08/13/2025 und führt die Börse als NASDAQ an. Die zu verkaufenden Aktien wurden durch Unternehmensprogramme erworben: 221 Aktien durch einen ESPP-Kauf am 03/13/2023 (bar bezahlt) und 2,839 Aktien aus dem Vesting von Restricted Stock am 03/02/2024, 03/03/2024 und 04/17/2024 als Vergütung.

Die Einreichung berichtet außerdem über einen früheren Verkauf durch Paul Blanchfield von 6,599 Stammaktien am 06/05/2025 mit Bruttoerlösen von $525,610.35. Bestimmte Identifikationsfelder des Meldenden erscheinen in den vorliegenden Inhalten leer. Das Dokument enthält die übliche Zusicherung des Verkäufers, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.

Positive
  • Acquisition sources disclosed: Shares being sold were acquired via ESPP and restricted stock vesting, which are standard compensation channels.
  • Full transaction details provided: Number of shares, acquisition dates, payment nature, broker, and planned sale date are all listed.
Negative
  • Recent prior sale disclosed: Paul Blanchfield sold 6,599 shares on 06/05/2025 for $525,610.35.
  • Filer identification incomplete: The provided extract shows empty filer identifier fields (CIK/CCC not populated).

Insights

TL;DR: Routine insider sale notice showing 3,060 shares from compensation sources; prior June sale of 6,599 shares.

The filing documents an intended sale under Rule 144 of 3,060 common shares valued at $163,924.20, scheduled for 08/13/2025 on NASDAQ via Fidelity. The shares were acquired through an ESPP and restricted stock vesting between 03/13/2023 and 04/17/2024, indicating these holdings originated from compensation rather than open-market purchases. The filing also discloses a recent sale of 6,599 shares on 06/05/2025 for $525,610.35, which is material for tracking insider liquidity but is a routine disclosure without additional context in this document.

TL;DR: Disclosure is procedural under Rule 144; acquisition dates and transaction types are clearly listed, but filer identifiers are incomplete.

The notice provides required acquisition details showing the 3,060 shares derive from an ESPP purchase and several restricted stock vesting events, with payment methods recorded as cash and compensation. This transparency supports compliance with Rule 144 requirements. However, the filing content supplied here has missing filer identification details (CIK/CCC not populated), limiting verifiability solely from this extract. The standard signature representation regarding absence of undisclosed material information is included.

Form 144 presentato per Lantheus Holdings, Inc (LNTH) segnala l'intenzione di vendere 3,060 azioni ordinarie tramite Fidelity Brokerage per un valore di mercato complessivo di $163,924.20. Il modulo indica la data approssimativa di vendita come 08/13/2025 e identifica il mercato come NASDAQ. Le azioni da vendere sono state acquisite tramite programmi aziendali: 221 azioni tramite un acquisto ESPP il 03/13/2023 (pagate in contanti) e 2,839 azioni risultanti dal vesting di restricted stock in data 03/02/2024, 03/03/2024 e 04/17/2024 come compenso.

La segnalazione riporta inoltre una vendita precedente di Paul Blanchfield di 6,599 azioni ordinarie il 06/05/2025 per proventi lordi di $525,610.35. Alcuni campi identificativi del dichiarante appaiono vuoti nel contenuto fornito. Il documento include la consueta dichiarazione del venditore secondo cui non esistono informazioni negative materiali non divulgate.

El Formulario 144 presentado para Lantheus Holdings, Inc (LNTH) revela la intención de vender 3,060 acciones ordinarias a través de Fidelity Brokerage por un valor de mercado agregado de $163,924.20. La presentación indica la fecha aproximada de venta como 08/13/2025 y identifica la bolsa como NASDAQ. Las acciones a vender se adquirieron mediante programas de la compañía: 221 acciones por una compra del ESPP el 03/13/2023 (pagadas en efectivo) y 2,839 acciones procedentes del vesting de restricted stock el 03/02/2024, 03/03/2024 y 04/17/2024 como compensación.

La presentación también informa de una venta anterior por parte de Paul Blanchfield de 6,599 acciones ordinarias el 06/05/2025 por unos ingresos brutos de $525,610.35. Algunos campos de identificación del declarante aparecen en blanco en el contenido proporcionado. El documento incluye la declaración estándar del vendedor de que no dispone de información material adversa no divulgada.

Form 144 제출서 — Lantheus Holdings, Inc (LNTH)에 따르면 Fidelity Brokerage를 통해 보통주 3,060주를 매도할 예정이며 총 시가총액은 $163,924.20입니다. 신고서에는 예정 매도일을 08/13/2025로 기재하고 있으며 거래소는 NASDAQ으로 명시되어 있습니다. 매도 예정 주식은 회사 프로그램을 통해 취득한 것으로, 221주는 ESPP 매수(일자: 03/13/2023, 현금 결제)를 통해 취득했고, 2,839주는 보상으로서 제한주(Restricted Stock)의 베스팅으로 03/02/2024, 03/03/2024, 04/17/2024에 취득했습니다.

신고서에는 또한 Paul Blanchfield06/05/2025에 보통주 6,599주를 매도해 총 $525,610.35의 총수익을 올렸다고 보고되어 있습니다. 제공된 내용에서는 일부 제출자 식별 필드가 비어 있는 것으로 보입니다. 문서에는 공개되지 않은 중대한 불리한 정보가 없다는 판매자 표준 진술이 포함되어 있습니다.

Le formulaire 144 déposé pour Lantheus Holdings, Inc (LNTH) indique l'intention de vendre 3,060 actions ordinaires via Fidelity Brokerage pour une valeur de marché totale de $163,924.20. Le dépôt mentionne la date approximative de vente comme 08/13/2025 et identifie la bourse comme NASDAQ. Les actions à vendre ont été acquises par le biais de programmes de l'entreprise : 221 actions via un achat ESPP le 03/13/2023 (payées en espèces) et 2,839 actions résultant du vesting de restricted stock le 03/02/2024, 03/03/2024 et 04/17/2024 en tant que rémunération.

Le dépôt signale aussi une vente antérieure par Paul Blanchfield de 6,599 actions ordinaires le 06/05/2025 pour un produit brut de $525,610.35. Certains champs d'identification du déclarant semblent vides dans le contenu fourni. Le document inclut la déclaration standard du vendeur selon laquelle il n'existe pas d'informations défavorables importantes non divulguées.

Form 144 eingereicht für Lantheus Holdings, Inc (LNTH) offenbart die beabsichtigte Veräußerung von 3,060 Stammaktien über Fidelity Brokerage mit einem aggregierten Marktwert von $163,924.20. Die Einreichung nennt das ungefähre Verkaufsdatum als 08/13/2025 und führt die Börse als NASDAQ an. Die zu verkaufenden Aktien wurden durch Unternehmensprogramme erworben: 221 Aktien durch einen ESPP-Kauf am 03/13/2023 (bar bezahlt) und 2,839 Aktien aus dem Vesting von Restricted Stock am 03/02/2024, 03/03/2024 und 04/17/2024 als Vergütung.

Die Einreichung berichtet außerdem über einen früheren Verkauf durch Paul Blanchfield von 6,599 Stammaktien am 06/05/2025 mit Bruttoerlösen von $525,610.35. Bestimmte Identifikationsfelder des Meldenden erscheinen in den vorliegenden Inhalten leer. Das Dokument enthält die übliche Zusicherung des Verkäufers, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the LNTH Form 144 disclose about planned insider sales?

The Form 144 shows a planned sale of 3,060 common shares valued at $163,924.20, to be sold via Fidelity on NASDAQ on 08/13/2025.

How were the shares that are being sold acquired according to the filing?

The filing lists acquisition sources as an ESPP purchase of 221 shares on 03/13/2023 (cash) and restricted stock vesting totaling 2,839 shares on 03/02/2024, 03/03/2024, and 04/17/2024 (compensation).

Did the filer recently sell any shares of LNTH?

Yes, the document reports that Paul Blanchfield sold 6,599 common shares on 06/05/2025 for gross proceeds of $525,610.35.

Which broker and exchange are involved in the planned sale?

The planned sale is through Fidelity Brokerage Services LLC and the securities are listed for sale on NASDAQ.

Does the filing include the seller's representation about material nonpublic information?

Yes, the filing includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.
Lantheus Holding

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Latest SEC Filings

LNTH Stock Data

3.66B
66.43M
2.23%
116.39%
11.9%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States
NORTH BILLERICA